Tooru (TOO)  has agreed to acquire 100% of Mylky B.V., a European plant-based milk machine brand, in a deal valued at £12 million.

The proposed acquisition includes £6 million in cash funded through existing resources and new debt, alongside a £3 million loan note and £3 million in new shares, representing about 10% to 15% of the enlarged group. The transaction remains conditional on due diligence, financing, documentation and shareholder approval.

Mylky produces home-use machines that allow consumers to make plant-based milk at a lower cost and without additives, aligning with growing demand for “free from” and sustainable products. The business operates across eight European markets and has built a customer base of more than 70,000.

Financially, Mylky is expected by its management to have generated revenue of €7.5 million and EBITDA of €2.5 million in 2025. Trading momentum has continued into 2026, with revenue projected to reach €9 million and EBITDA €3.1 million for the 12 months to 31 March 2026.

Tooru said the acquisition would complement its existing brands Juvela, OAF and Pulsin, while creating cross-selling and co-branding opportunities. In addition, the company sees scope to expand Mylky into new markets, including the UK, and develop subscription-based ingredient offerings.

Tooru’s CEO Scott Livingston said: “We are very excited about the opportunity to grow Mylky and to build it alongside Pulsin, Juvela and OAF. We see many interesting ideas and innovation potential for home based "free-from" food and drink production and subscription/regime type offerings. The acquisition of this profitable business would both enhance and add scale to the Tooru group that will help its public journey in the short term and create value for our shareholders. The team at Mylky are exceptional and we all look forward to working together going forward. We believe that this is very much the first step in the implementation of our stated buy and build strategy.”

View from Vox

This is a clear execution of Tooru’s buy-and-build strategy, adding a fast-growing, high-margin brand in a structurally expanding plant-based market. The combination of strong cash generation and clear synergies suggests potential for near-term scale and longer-term portfolio expansion.